Tomoko Fujikawa
Overview
Explore the profile of Tomoko Fujikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uemura S, Kishimoto K, Fujikawa T, Nakamura S, Kozaki A, Saito A, et al.
Pediatr Int
. 2024 Dec;
66(1):e15836.
PMID: 39692193
Background: This study aimed to evaluate whether an early elevation of absolute eosinophil count after allogeneic hematopoietic stem cell transplantation (allo-HSCT) was associated with the development of chronic graft-versus-host disease...
2.
Morishita Y, Hamada M, Uemura S, Kikuchi H, Hisakawa H, Fujikawa T, et al.
Pediatr Blood Cancer
. 2024 Nov;
72(2):e31465.
PMID: 39616414
Aplastic anemia, mental retardation, and dwarfism syndrome (AMeDS) is a rare inherited bone marrow failure syndrome. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only possible treatment option for hematological...
3.
Nakatani N, Win K, Mon C, Fujikawa T, Uemura S, Saito A, et al.
Biology (Basel)
. 2024 May;
13(5).
PMID: 38785826
Non-high-risk (non-HR) neuroblastoma (NB) patients have excellent outcomes, with more than a 90% survival rate, whereas HR NB patients expect less than a 50% survival rate. Metastatic disease is the...
4.
Fujikawa T, Uemura S, Hasegawa D, Morisada N, Nakamura S, Kozaki A, et al.
Pediatr Blood Cancer
. 2024 Mar;
71(6):e30736.
PMID: 38523246
No abstract available.
5.
Inoue S, Win K, Mon C, Fujikawa T, Hyodo S, Uemura S, et al.
Oncol Lett
. 2023 Aug;
26(3):369.
PMID: 37559575
More than half of patients with high-risk neuroblastoma (HR-NB) experience relapse/regrowth due to the activation of chemoresistant minimal residual disease (MRD). MRD in patients with HR-NB can be evaluated by...
6.
Uemura S, Hasegawa D, Kishimoto K, Fujikawa T, Nakamura S, Kozaki A, et al.
Cancer Med
. 2023 Jul;
12(16):17018-17027.
PMID: 37434385
Background: The present study aimed to examine the association between the conditioning intensity and height growth in pediatric patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods: We reviewed...
7.
Mizuno S, Fujikawa T, Uemura S, Hasegawa D, Kosaka Y, Kasai M
BMC Infect Dis
. 2023 Feb;
23(1):95.
PMID: 36788492
Background: Coagulase-negative staphylococci can cause hospital-acquired infections, especially in immunocompromised hosts. Bacterial meningitis is a potentially fatal infection of the central nervous system, causing high mortality and morbidity. In general,...
8.
Fujikawa T, Uemura S, Yoshida M, Hyodo S, Kozaki A, Saito A, et al.
Oncol Lett
. 2022 Nov;
24(6):452.
PMID: 36380878
Infantile fibrosarcoma (IFS) commonly harbors ETS variant transcription factor 6 ()-neurotrophic receptor tyrosine kinase 3 () fusion. However, the recent accessibility to clinical next-generation sequencing (NGS) has revealed negative spindle...
9.
Fujikawa T, Kishimoto K, Inoue S, Nishimura A, Tojo R, Uemura S, et al.
Intern Med
. 2022 Jul;
62(3):453-457.
PMID: 35793962
We herein report a rare case of spinal cord compression due to epidural involvement of acute myeloid leukemia (AML). A 14-year-old boy presented with a 7-day history of back pain,...
10.
Nakashita M, Takagi Y, Tanaka H, Nakamura H, Serizawa Y, Ukai T, et al.
Open Forum Infect Dis
. 2022 May;
9(5):ofac158.
PMID: 35531379
Background: Singing in an indoor space may increase the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a case-control study of karaoke-related coronavirus disease 2019 (COVID-19)...